Ridgewood Investments LLC cut its position in shares of CME Group Inc (NASDAQ:CME) by 4.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,032 shares of the financial services provider’s stock after selling 53 shares during the period. Ridgewood Investments LLC’s holdings in CME Group were worth $207,000 at the end of the most recent quarter.
Other hedge funds have also recently added to or reduced their stakes in the company. Evoke Wealth LLC purchased a new position in shares of CME Group during the 3rd quarter worth about $27,000. Thor Advisors LLC purchased a new position in shares of CME Group during the 3rd quarter worth about $34,000. Venturi Wealth Management LLC purchased a new position in shares of CME Group during the 3rd quarter worth about $36,000. Bartlett & Co. LLC boosted its stake in shares of CME Group by 2,471.4% during the 3rd quarter. Bartlett & Co. LLC now owns 180 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 173 shares during the period. Finally, Independence Bank of Kentucky purchased a new position in shares of CME Group during the 3rd quarter worth about $40,000. 84.14% of the stock is owned by hedge funds and other institutional investors.
In other news, Director Ronald A. Pankau sold 300 shares of the business’s stock in a transaction dated Thursday, November 7th. The shares were sold at an average price of $199.02, for a total value of $59,706.00. Following the completion of the sale, the director now owns 3,906 shares in the company, valued at approximately $777,372.12. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Martin J. Gepsman sold 1,000 shares of the business’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $201.16, for a total transaction of $201,160.00. Following the completion of the sale, the director now owns 34,905 shares of the company’s stock, valued at approximately $7,021,489.80. The disclosure for this sale can be found here. Insiders have sold a total of 40,609 shares of company stock valued at $8,216,221 in the last quarter. 1.20% of the stock is currently owned by company insiders.
Shares of CME opened at $205.01 on Thursday. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $224.91. The company has a 50-day moving average of $203.77 and a 200 day moving average of $206.89. The firm has a market capitalization of $72.95 billion, a price-to-earnings ratio of 30.06, a PEG ratio of 3.46 and a beta of 0.18. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.04 and a quick ratio of 1.04.
CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, beating analysts’ consensus estimates of $1.75 by $0.15. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.27 billion. During the same quarter last year, the business posted $1.45 EPS. The firm’s revenue for the quarter was up 41.3% on a year-over-year basis. On average, equities analysts anticipate that CME Group Inc will post 6.81 earnings per share for the current fiscal year.
The business also recently disclosed a dividend, which was paid on Wednesday, January 15th. Investors of record on Friday, December 27th were issued a dividend of $2.50 per share. This is a positive change from CME Group’s previous dividend of $1.75. The ex-dividend date of this dividend was Thursday, December 26th. CME Group’s dividend payout ratio (DPR) is presently 43.99%.
A number of research firms recently commented on CME. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Friday, January 10th. Citigroup lifted their price target on shares of CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. ValuEngine lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Credit Suisse Group began coverage on shares of CME Group in a report on Monday, December 16th. They set a “neutral” rating for the company. Finally, UBS Group lifted their price objective on shares of CME Group from $218.00 to $221.00 and gave the company a “neutral” rating in a report on Wednesday, December 4th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $208.36.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Article: Inverted Yield Curve
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.